• LDS
  • /Medical Tests
  • /Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome

Diseases (2)
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Overview
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Clinical Utility
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Interpretation
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Reference Ranges
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Methodology
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Specimen Collection
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Additional Testing
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Turnaround Time
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

CPT
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

LOINC
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

ICD10
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Additional ICD10
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

References
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.

Panel Test Components
Access to Tumor Suppressor Gene P53 (TP53) Mutation Analysis, Li-Fraumeni Syndrome is restricted.